Actinic Keratoses
Actinic keratoses (AKs) are rough, scaly patches or lesions that develop on skin chronically exposed to ultraviolet (UV) radiation from the sun or tanning beds. These lesions are considered precancerous because they can progress into squamous cell carcinoma (SCC), a common form of skin cancer. While only a small percentage of AKs will become cancerous, individuals with multiple lesions are at significantly higher risk. Early detection and treatment are crucial for preventing progression to skin cancer.
AKs typically appear on sun-exposed areas of the body such as the face, ears, scalp (especially in balding individuals), neck, forearms, hands, chest, legs, and lips. When they form on the lower lip, the condition is referred to as actinic cheilitis, a more aggressive subtype that requires careful monitoring.
Dr. Brian Hibler diagnoses AKs through a clinical skin examination, often aided by dermoscopy, a non-invasive magnification tool that allows for close-up inspection of the lesion’s structure, pigment patterns, and vascular features.
If a lesion appears suspicious for skin cancer, a biopsy may be performed to confirm the diagnosis and rule out squamous cell carcinoma or another skin cancer.
If you notice persistent rough spots or scaly patches on sun-exposed areas or have a personal history of skin cancer or extensive sun exposure, early evaluation is essential. Dr. Brian Hibler, a board-certified and Harvard fellowship-trained medical and cosmetic dermatologist in Manhattan, offers comprehensive care for actinic keratoses and sun-damaged skin. [Did you know? Laser treatments are FDA-approved for treating AKs and sun-damaged skin. LINK TO FRAXEL] A personalized treatment plan including FDA approved laser treatments can help protect your skin’s health and your future. Schedule a consultation with Dr. Brian Hibler at his Manhattan office today.
At a Glance
Dr. Brian Hibler
- Board-certified dermatologist
- Fellowship-trained dermatologist
- Ivy League educated at Cornell and Harvard Medical School
- Learn more